Ceribell’s LVO Stroke is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...
Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This ...
Amplifi Vascular, Inc., a developer of solutions for hemodialysis vascular access, announced it has been granted Breakthrough ...
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
The Skincubator is a wearable designed to enable immediate, prolonged skin-to-skin care for the tiniest preterm infants in ...
Zacks Investment Research on MSN
CBLL wins FDA breakthrough status for AI-based LVO stroke detection
CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...
Protara Therapeutics stock (TARA) and CeriBell stock (CBLL) gain as the FDA issues breakthrough designations for their ...
TAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ -- Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S.
SECAUCUS, N.J., Aug. 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results